Oncology
Immuno Oncology
Anti-Virus
Disease Modeling
Cosmetics
Toxicity
Spatial Biology
Technology Service
Cancer Organoid
Research Service
Others
Summary:
Pfizer terminates collaboration on hemophilia A gene therapy, impacting Sangamo’s stock.
Pfizer has ended its partnership with Sangamo Therapeutics on the hemophilia A gene therapy, giroctocogene fitelparvovec, leading to a 56% drop in Sangamo’s stock. Pfizer will return rights to Sangamo by April 2025.
Summary:
GSK partners with Relation Therapeutics to develop treatments for osteoarthritis and fibrotic diseases.
GSK has entered a $300 million partnership with London-based Relation Therapeutics to develop new treatments for osteoarthritis and fibrotic diseases, leveraging machine learning for drug discovery.
Summary:
Autolus gains FDA approval for Aucatzyl, a CAR-T cell therapy for leukemia.
Autolus, a UK biotech company, has received FDA approval for Aucatzyl, a new CAR-T cell therapy for acute lymphoblastic leukemia, aiming to reduce side effects associated with existing treatments.
Summary:
The organoids market is set to grow rapidly due to advancements in biotechnology and increased demand for personalized medicine.
A report predicts the global organoids market will reach $12.8 billion by 2030, driven by innovations in drug discovery, regenerative medicine, and personalized healthcare. The market shows exponential growth potential
Summary:
Biopharma companies are urged to focus on robust data to secure venture capital investments in 2025.
A PitchBook report highlights that venture capitalists prioritize biopharma companies with strong data in areas like clinical trials and patient outcomes, making data a critical factor for funding success.
@ 2024 . All rights reserved
@ 2024 . All rights reserved
